Skip to main content
. 2018 Jul 12;13(8):1144–1152. doi: 10.2215/CJN.13811217

Figure 4.

Figure 4.

Cumulative incidence of treatment change during follow-up among matched direct oral anticoagulant users and warfarin users with atrial fibrillation. *Baseline time for warfarin users (A) is the warfarin prescribed date matched with duration of previous warfarin use, in comparison with direct oral anticoagulant users (B). Thirty-nine percent of discontinuation of anticoagulant occurred after bleeding events.